INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,394 | -65.8% | 1,312 | -55.7% | 0.00% | -100.0% |
| Q2 2021 | $27,458 | -0.1% | 2,962 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $27,487 | +136.7% | 2,962 | +125.8% | 0.00% | 0.0% |
| Q4 2020 | $11,611 | -33.2% | 1,312 | -12.4% | 0.00% | 0.0% |
| Q3 2020 | $17,377 | -89.8% | 1,498 | -76.2% | 0.00% | -92.3% |
| Q2 2020 | $169,677 | +1408.4% | 6,296 | +316.4% | 0.01% | +1200.0% |
| Q1 2020 | $11,249 | +876.5% | 1,512 | +333.2% | 0.00% | – |
| Q4 2019 | $1,152 | -89.5% | 349 | -93.5% | 0.00% | -100.0% |
| Q3 2019 | $10,965 | -79.1% | 5,349 | -70.0% | 0.00% | -80.0% |
| Q2 2019 | $52,400 | -21.2% | 17,823 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $66,480 | -71.9% | 17,823 | -69.9% | 0.01% | -77.4% |
| Q4 2018 | $236,492 | -28.1% | 59,123 | 0.0% | 0.03% | -13.9% |
| Q3 2018 | $328,724 | +41.8% | 59,123 | 0.0% | 0.04% | +33.3% |
| Q2 2018 | $231,762 | -16.8% | 59,123 | 0.0% | 0.03% | -20.6% |
| Q1 2018 | $278,469 | +14.0% | 59,123 | 0.0% | 0.03% | +13.3% |
| Q4 2017 | $244,178 | -34.9% | 59,123 | 0.0% | 0.03% | -38.8% |
| Q3 2017 | $374,840 | – | 59,123 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|